Advanced search
Publication Cover
Leukemia & Lymphoma Volume 50, 2009 - Issue 10
Submit an article Journal homepage
84
Views
9
CrossRef citations to date
0
Altmetric
Letters to the Editor

CD56-negative extranodal nasal type of natural killer/T-cell lymphoma with extranasal skin involvement

Mo Xiang Lan Department of Pathology; Hematology, People's Hospital of Guangxi Province, Nanning, Guangxi, ChinaCorrespondence[email protected]
,
Zhou Xiang Zhen Department of Pathology
&
Wei Hai Ming Department of Pathology
Pages 1715-1717 | Received 27 May 2009, Accepted 17 Jul 2009, Published online: 08 Oct 2009

References

  • Chan J KC, Quintanilla-Martinez L, Ferry J A, Peh S C. Extranodal NK/T cell lymphoma, nasal type. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues4 th ed., S H Swerdlow, E Campo, N K Harris, S A Pileri, H Stein, J Thiele, J W Vardiman. IARC press, Lyon 2008; 285–288
  • Ng S B, Lai K W, Murugaya S, et al. Nasal-type extranodal natural killer/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore. Mod Pathol 2004; 17: 1097–1107
  • Katsaounis P, Alexopoulou A, Dourakis S P, et al. An extranodal NK/T cell lymphoma, nasal type, with specific immunophenotypic and genotypic features. Int J Hematol 2008; 88: 202–205
  • Chang B H, Stork L, Fan G. A unique case of adolescent CD56-negative extranodal NK/T-cell lymphoma, nasal type. Pediatr Dev Pathol 2008; 11: 50–54
  • Stokkermans-Dubois J, Jouary T, Vergier B, Delaunay M M, Taieb A. A case of primary cutaneous nasal type NK/T-cell lymphoma and review of the literature. Dermatology 2006; 213: 345–349
  • Choi Y L, Park J H, Namkung J H, et al. Extranodal NK/T-cell lymphoma with cutaneous involvement: ‘nasal’vs.‘nasal-type’ subgroups – a retrospective study of 18 patients. Br J Dermatol 2009; 160: 333–337
  • Xiang-Lan M, Zu-Lan S, He Dan, Bi-Hong S, Pang-Ya Q, Han-Liang L. Skp2/p27 expression profile is correlated with Epstein-Barr virus status in extranodal nasal-type natural killer cell lymphoma. Transl Res 2008; 151: 303–308
  • Ruskova A, Thula R, Chan G. Aggressive natural killer-cell leukemia: report of five cases and review of the literature. Leuk Lymphoma 2004; 45: 2427–2438
  • Yamaguchi M, Suzuki R, Kwong Y L, et al. Phase I study of dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia. Cancer Sci 2008; 99: 1016–1020
  • Bang S M, Kim Y K, Park Y H, et al. High-dose therapy and autologous stem cell transplantation in Korean patients with aggressive T/NK-cell lymphoma. Lymphoma 2005; 46: 1599–1604
  • Murashige N, Kami M, Kishi Y, et al. Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms. Br J Haematol 2005; 130: 561–567

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.